Irinotecan, Capecitabine and Bevacizumab in Metastatic Colorectal Cancer Patients

ABSTRACT: The purpose of this study is to determine efficacy and safety of the biweekly scheme with Capecitabine and Irinotecan, plus bevacizumab in patients with metastatic colorectal cancer.

DISEASE(S): Metastatic Colorectal Cancer,Cáncer Colorrectal Metastásico No Pretratado,Colorectal Neoplasms,Colorectal Cancer Nos

PROVIDER: 2070371 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR